Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024
Compare Balance Sheet Results of Genomic Valley
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.05
5.09
-2.04
-40.08%
Share Warrants & Outstandings
Total Reserve
0.84
4.41
-3.57
-80.95%
Shareholder's Funds
3.90
9.50
-5.60
-58.95%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
1.74
-1.74
-100.00%
Secured Loans
0.00
1.74
-1.74
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.01
0.01
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.42
-0.42
-100.00%
Total Non-Current Liabilities
0.00
2.15
-2.15
-100.00%
Current Liabilities
Trade Payables
0.01
1.12
-1.11
-99.11%
Other Current Liabilities
0.36
0.73
-0.37
-50.68%
Short Term Borrowings
0.00
2.34
-2.34
-100.00%
Short Term Provisions
0.09
0.12
-0.03
-25.00%
Total Current Liabilities
0.46
4.30
-3.84
-89.30%
Total Liabilities
4.36
15.95
-11.59
-72.66%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.01
12.93
-12.92
-99.92%
Less: Accumulated Depreciation
0.00
6.92
-6.92
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.01
6.01
-6.00
-99.83%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.20
-0.20
-100.00%
Long Term Loans & Advances
1.73
0.23
1.50
652.17%
Other Non Current Assets
0.00
0.48
-0.48
-100.00%
Total Non-Current Assets
1.73
6.91
-5.18
-74.96%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.28
1.90
-1.62
-85.26%
Sundry Debtors
2.21
5.46
-3.25
-59.52%
Cash and Bank
0.05
0.81
-0.76
-93.83%
Other Current Assets
0.00
0.39
-0.39
-100.00%
Short Term Loans and Advances
0.08
0.48
-0.40
-83.33%
Total Current Assets
2.62
9.04
-6.42
-71.02%
Net Current Assets (Including Current Investments)
2.16
4.74
-2.58
-54.43%
Total Current Assets Excluding Current Investments
2.62
9.04
-6.42
-71.02%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
4.36
15.95
-11.59
-72.66%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
4.07
-4.07
-100.00%
Book Value per share (adjusted)
12.76
18.66
-5.90
-31.62%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.01 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 2.62 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024
